Trial
NCT01056601
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
Novartis Pharmaceuticals; Millennium Pharmaceuticals, Inc.
Condition
Pancreatic Cancer
Intervention
Bortezomib
Why stopped
Funding not available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28